4//SEC Filing
Ehrlich Christopher B 4
Accession 0001213900-24-084830
CIK 0001870404other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 9:53 PM ET
Size
10.8 KB
Accession
0001213900-24-084830
Insider Transaction Report
Form 4
Ehrlich Christopher B
DirectorChairman and CEO
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2024-09-30−572,182→ 0 totalExercise: $1.77Exp: 2034-03-24→ Common Stock (572,182 underlying) - Exercise/Conversion
Common Stock
2024-09-25+5,312,983→ 5,791,808 total - Exercise/Conversion
Series A Convertible Preferred Stock
2024-09-25$1000.00/sh−275$275,000→ 0 total→ Common Stock (5,312,983 underlying)
Holdings
- 3,600(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]On September 25, 2024, the Reporting Person converted an aggregate of 275 shares of Series A Preferred Stock into 5,312,983 shares of Common Stock. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price of $1.00. As a result of various adjustments in the terms of the Series A Preferred Stock, each $1,000 of Series A Preferred Stock was converted into 19,320 shares of common stock. The Series A Preferred Stock has no expiration date.
- [F2]Represents the forfeiture of employee stock options in connection with the Reporting Person's appointment as Chief Executive Officer of the Issuer.
Documents
Issuer
CERO THERAPEUTICS HOLDINGS, INC.
CIK 0001870404
Entity typeother
Related Parties
1- filerCIK 0001293973
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 9:53 PM ET
- Size
- 10.8 KB